Full video transcriptClick to expand
Auto-generated transcript of @ztspeaks's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.
- 0:00So a lot of drug addicts now are getting off substances and replacing it for things like
- 0:04TRT, you know, a bunch of peptides and things like that.
- 0:08Now what do I think of that idea?
- 0:10Well, you know, I think that's better than the fucking substance addiction, not even going
- 0:15to lie, you know, at least it is functional.
- 0:17At least, you know, the stuff isn't inherently addictive despite, you know, you having to
- 0:21cut it beyond your entire life as you want a massive hormone crash.
- 0:26You know, I think it's a better idea than the fucking substance addiction that's going
- 0:30to put you in the ground and that has zero upsides except for numbing out your pain obviously.
- 0:35And then, you know, the pain gets way worse years later and you live in this constant state
- 0:41of feeding.
- 0:42So, you know, there are benefits to the other route, you know, and peptides and stuff.
- 0:46The only thing that scares me about the peptides is the fact that, you know, long-term data
- 0:51is not very, you know, concise.
- 0:54However, they are just amino acid chains and, you know, they are naturally occurring
- 0:58in the body.
- 0:59But also, they are a Chinese research chemical yoriting off some sketchy side.
- 1:03So, that's the hardest part about it.
- 1:04You know, I'm still nervous to use that shit, but, you know, I think it's a lot better and
- 1:08safer than, you know, a drug addiction without a doubt.
Peptides and addiction recovery: what the science actually says
Quick answer
The video touches on an emerging but poorly studied area: whether peptides with dopaminergic or anxiolytic mechanisms, such as BPC-157 or selank, could support addiction recovery. Current evidence is limited to animal models and small observational data, with no regulatory-approved indication for any peptide in addiction treatment. The TRT component carries its own clinical complexity, including hypothalamic-pituitary-gonadal axis suppression requiring medical supervision for any discontinuation.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 6 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For Peptides and addiction recovery: what the science actually says, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Functional Connectomic Approach to Studying Selank and Semax Effects
Small Russian fMRI study (52 healthy volunteers) of brain connectivity after Semax or Selank; mechanistic and exploratory, not a clinical efficacy trial.
PubMed
Effects of Semax on the Default Mode Network of the Brain
Small human fMRI study (24 adults) of intranasal Semax on brain networks; an imaging-marker study with no clinical outcomes, not replicated outside the originating group.
PubMed
Multifunctionality and Possible Medical Application of the BPC 157 Peptide
Used to frame BPC-157 as an investigational peptide with mixed preclinical and limited human evidence.
PubMed
Gastric pentadecapeptide BPC 157 and its role in accelerating musculoskeletal soft tissue healing
Supports cautious tissue-repair context without presenting BPC-157 as an approved therapy.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
Peptides and addiction recovery: what the science actually says is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.
Helpful context before the funnel
Page-specific review note
What this exact clip is really saying
This FormBlends review is specific to "Peptides and addiction recovery: what the science actually says" from Zt. We read the clip as a Peptide social video fact-checks claim about Peptide social video fact-checks, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The video touches on an emerging but poorly studied area: whether peptides with dopaminergic or anxiolytic mechanisms, such as BPC-157 or selank, could support addiction recovery.
The reason this review is not generic is the source wording and the canonical claim label "peptides addicts are now using peptides often addictionrecovery addic." In this clip, the useful excerpt is: "So a lot of drug addicts now are getting off substances and replacing it for things like TRT, you know, a bunch of peptides and things like that." That wording changes the review because it points to Peptide social video fact-checks evidence, safety, and patient-fit context, not a one-size-fits-all protocol.
The source trail for this page is checked against Functional Connectomic Approach to Studying Selank and Semax Effects (2020), Effects of Semax on the Default Mode Network of the Brain (2018), and Therapeutic Peptides: Applications, Challenges, and Future Directions (2026), plus the creator's own wording. Peptide social video fact-checks decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.
Claim verdict
The useful answer behind this video
This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.
Claim being checked
The video touches on an emerging but poorly studied area: whether peptides with dopaminergic or anxiolytic mechanisms, such as BPC-157 or selank, could support addiction recovery.
FormBlends verdict
Peptide social video fact-checks evidence, safety, and patient-fit context
Evidence strength
Source-backed review with clinical or regulatory citations.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- The video touches on an emerging but poorly studied area: whether peptides with dopaminergic or anxiolytic mechanisms, such as BPC-157 or selank, could support addiction recovery. Current evidence is limited to animal models and small observational data, with no regulatory-approved indication for any peptide in addiction treatment. The TRT component carries its own clinical complexity, including hypothalamic-pituitary-gonadal axis suppression requiring medical supervision for any discontinuation.
- Zero FDA-approved peptides exist for addiction treatment as of 2024. Any claim otherwise is not supported by regulatory evidence.
- BPC-157 reduced alcohol-seeking behavior in rat models (Vukojevic et al., 2021, Brain and Behavior), but this has not been replicated in controlled human addiction trials.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Zero FDA-approved peptides exist for addiction treatment as of 2024. Any claim otherwise is not supported by regulatory evidence.
- BPC-157 reduced alcohol-seeking behavior in rat models (Vukojevic et al., 2021, Brain and Behavior), but this has not been replicated in controlled human addiction trials.
- A 2023 Drug Testing and Analysis study found significant mislabeling and contamination in commercially sourced research peptides, making gray-market sourcing a documented clinical risk.
- Testosterone replacement therapy creates physiological dependency on exogenous hormone; stopping without medical supervision causes documented hypogonadism, not a minor inconvenience.
- Selank and semax show anxiolytic activity in Russian clinical literature, but these studies have not been replicated under Western regulatory trial standards and cannot be treated as equivalent evidence.
- The creator's harm reduction framing, comparing peptide use to active polysubstance addiction, reflects a real clinical conversation but is not a substitute for evidence-based addiction medicine.
- Anyone considering peptides in a recovery context should consult a licensed clinician. Peptide therapy is not a validated or approved addiction recovery protocol.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.
What did @ztspeaks actually say?
The creator's argument, stripped down, is this: people leaving drug addiction are turning to TRT and peptides, and while that swap isn't perfect, it beats active substance abuse. He calls peptides "just amino acid chains" that are "naturally occurring in the body," but immediately hedges by calling them "a Chinese research chemical" from "sketchy" sources. Credit where it's due: he didn't sell peptides as a cure. He expressed genuine uncertainty about long-term safety data, and that honesty is more than most peptide content on TikTok bothers with. His framing is harm reduction, not hype, which puts this video in a different category than the usual "this peptide fixed my life" content flooding the algorithm.
Does the science back this up?
Partially, but the picture is messier than the video implies. The harm reduction logic has real merit. What the science does not yet support is any clinical claim that peptides are a validated recovery tool for addiction.
On the harm reduction side: peptides like BPC-157 have shown preclinical signals relevant to addiction recovery. A 2021 paper by Vukojevic et al. in Brain and Behavior found BPC-157 modulated dopaminergic pathways in rat models, reducing alcohol-driven behavior. Selank and semax, both studied in Russian clinical settings, show anxiolytic and nootropic activity that could theoretically ease withdrawal-related anxiety. But "preclinical signals" and "could theoretically" are doing a lot of heavy lifting there. None of these peptides have completed Phase III trials for addiction indications in Western regulatory frameworks. The creator is right that long-term data is not, as he puts it, "very concise." That's an understatement.
On TRT: the evidence for testosterone replacement as an addiction recovery tool is even thinner. Some research links low testosterone to higher rates of opioid use disorder (Daniell, 2002, Journal of Pain), but that's correlation, not a treatment protocol.
What did they get wrong (or right)?
The "naturally occurring" framing deserves pushback. He says peptides are "just amino acid chains" and "naturally occurring in the body," which is technically true of many peptides but misleading as a safety argument. Insulin is also naturally occurring. That doesn't mean injecting unregulated, unverified peptide vials from gray-market suppliers is low-risk. Purity, sterility, and accurate dosing are real concerns with research-chemical peptides, and those risks are not canceled out by biochemical origin.
He actually gets the supply chain risk right, calling out "sketchy" sourcing. A 2023 analysis by Cantu-Medellin et al. published in Drug Testing and Analysis found significant labeling inaccuracies in commercially available research peptides, including incorrect concentrations and contamination markers. That's the risk he's nervous about, and he should be.
Where he's on solid ground: the baseline comparison to active addiction is fair. Uncontrolled polysubstance use carries mortality risk that no current peptide product approaches, based on available data.
What should you actually know?
If you or someone you know is exploring peptides as part of a recovery journey, here is what the evidence actually supports:
- No peptide is FDA-approved for addiction treatment. Full stop.
- Gray-market peptide sourcing carries real contamination and mislabeling risk, as documented in peer-reviewed analysis, not just anecdote.
- The harm reduction framing in this video is not medically endorsed, but it does reflect a real conversation happening in addiction medicine about testosterone deficiency, neuroinflammation, and recovery.
- TRT involves real physiological dependency. Stopping exogenous testosterone without medical guidance causes the "massive hormone crash" the creator describes. That is not trivial.
- If peptides interest you in a recovery context, that conversation belongs with a licensed clinician who can assess your specific situation, not a TikTok comment section.
The creator's instinct to be nervous about unregulated peptide products is the most medically sound thing in this video. Follow that instinct.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Zt · TikTok creator
27.6K views on this video
Addicts are now using peptides often. #addictionrecovery #addiction #addictionawareness #sobrietyjourney
Frequently asked questions
Quick answers based on this video and our medical team review.
What does the video say about zero fda-approved peptides exist for addiction treatment as of 2024.?
Zero FDA-approved peptides exist for addiction treatment as of 2024. Any claim otherwise is not supported by regulatory evidence.
What does the video say about bpc-157 reduced alcohol-seeking behavior in rat models (vukojevic et al.,?
BPC-157 reduced alcohol-seeking behavior in rat models (Vukojevic et al., 2021, Brain and Behavior), but this has not been replicated in controlled human addiction trials.
What does the video say about a 2023 drug testing?
A 2023 Drug Testing and Analysis study found significant mislabeling and contamination in commercially sourced research peptides, making gray-market sourcing a documented clinical risk.
What does the video say about testosterone replacement therapy creates physiological dependency on exogenous hormone; stopping?
Testosterone replacement therapy creates physiological dependency on exogenous hormone; stopping without medical supervision causes documented hypogonadism, not a minor inconvenience.
What does the video say about selank?
Selank and semax show anxiolytic activity in Russian clinical literature, but these studies have not been replicated under Western regulatory trial standards and cannot be treated as equivalent evidence.
What does the video say about the creator's harm reduction framing, comparing peptide use to active?
The creator's harm reduction framing, comparing peptide use to active polysubstance addiction, reflects a real clinical conversation but is not a substitute for evidence-based addiction medicine.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Zt, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.